Stroke Prevention for Patients with Atrial Fibrillation: Beyond the Guidelines
Key result
Current guidelines do not account for arrhythmia pattern or duration, and further research is needed to guide management of subclinical and stress-induced transient atrial fibrillation.
Population
Patients with atrial fibrillation
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Guidelines omit AF pattern and duration from risk assessment; leaves open evidence-based stroke prevention for subclinical and transient AF.
Key Points
- To review clinical scenarios where current clinical guidelines lack sufficient high-quality evidence to guide stroke risk stratification and oral anticoagulation decisions in atrial fibrillation.
- Narrative review analyzing the stroke risk conferred by patterns of atrial fibrillation, device-detected subclinical episodes, and stress-related transient episodes.
- Oral anticoagulation therapy reduces ischemic stroke risk by approximately two-thirds and all-cause mortality by approximately one-quarter in patients with atrial fibrillation, but confers an increased bleeding risk.
- Current clinical guidelines offer limited guidance for stroke prevention in emerging clinical scenarios, specifically device-detected subclinical atrial fibrillation (SCAF) and atrial fibrillation occurring transiently with stress (AFOTS).
Structured PICO
P
Population
A review of emerging areas in stroke prevention for patients with atrial fibrillation, focusing on arrhythmia burden, subclinical atrial fibrillation, and stress-induced transient atrial fibrillation.
I
Intervention
Oral anticoagulation (OAC) therapy
O
Outcome
Ischemic stroke
Highlights the need for high-quality evidence to guide stroke risk stratification in emerging clinical scenarios of atrial fibrillation not fully addressed by current guidelines.
Limitations
- Most studies on AFOTS used relatively insensitive methods to detect recurrent AF, likely underestimating the true recurrence rate.
Cite This Study
Jeff S. Healey (2017) conducted a review in Atrial fibrillation. Oral anticoagulation and risk stratification was evaluated. Current guidelines do not account for arrhythmia pattern or duration, and further research is needed to guide management of subclinical and stress-induced transient atrial fibrillation.